Integer Holdings Corporation (FRA:WGB)

Germany flag Germany · Delayed Price · Currency is EUR
76.50
+0.50 (0.66%)
Last updated: Jun 3, 2026, 8:05 AM CET
Market Cap2.63B -29.1%
Revenue (ttm)1.61B +6.3%
Net Income123.04M +84.4%
EPS3.44 +82.2%
Shares Out n/a
PE Ratio21.42
Forward PE14.01
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open76.50
Previous Close76.00
Day's Range76.50 - 76.50
52-Week Range54.00 - 106.00
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateJul 30, 2026

About Integer Holdings

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, impl... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1970
Employees 11,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol WGB

Financial Performance

In 2025, Integer Holdings's revenue was $1.85 billion, an increase of 7.98% compared to the previous year's $1.72 billion. Earnings were $102.81 million, a decrease of -14.25%.

Financial numbers in USD Financial Statements

News

Integer to Participate in Truist Securities 2026 MedTech Conference on June 16

PLANO, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced participation i...

4 hours ago - GlobeNewsWire

Integer price target raised to $92 from $89 at Citi

Citi analyst Joanne Wuensch raised the firm’s price target on Integer (ITGR) to $92 from $89 and keeps a Neutral rating on the shares. The firm updated models in the…

6 days ago - TheFly

Oppenheimer upgrades Integer to Outperform as checks suggest PE CMO interest

As previously reported, Oppenheimer analyst Suraj Kalia upgraded Integer (ITGR) to Outperform from Perform with a $115 price target The firm notes Integer recently announced a strategic review process...

21 days ago - TheFly

Integer upgraded to Outperform from Perform at Oppenheimer

Oppenheimer upgraded Integer (ITGR) to Outperform from Perform with a $115 price target

21 days ago - TheFly

Integer Holdings Transcript: Bank of America Global Healthcare Conference 2026

Outsourcing remains the dominant trend, with strong industry positioning and a diversified portfolio supporting growth. Strategic review is underway due to heightened interest, with a decision expected in months. Guidance was lowered mainly due to short-term EP inventory adjustments, but robust pipeline and margin improvement initiatives support confidence in long-term outperformance.

21 days ago - Transcripts

Integer price target lowered to $89 from $92 at Citi

Citi lowered the firm’s price target on Integer (ITGR) to $89 from $92 and keeps a Neutral rating on the shares.

4 weeks ago - TheFly

Integer price target raised to $98 from $91 at BofA

BofA analyst Craig Bijou raised the firm’s price target on Integer (ITGR) to $98 from $91 and keeps a Neutral rating on the shares. Despite the Q1 revenue beat, the…

4 weeks ago - TheFly

Integer initiates strategic review

Integer (ITGR) announced that its board of directors has initiated a strategic review. In consultation with its financial and legal advisors, the board will consider a full range of potential…

4 weeks ago - TheFly

Integer Holdings Earnings Call Transcript: Q1 2026

Q1 2026 results met expectations with modest sales growth but lower margins and EPS. 2026 guidance was revised downward due to temporary headwinds in electrophysiology and risk adjustments, while a strategic review was launched amid increased external interest.

4 weeks ago - Transcripts

Integer Holdings Slides: Q1 2026

Integer Holdings has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.

4 weeks ago - Filings

Integer Holdings Earnings release: Q1 2026

Integer Holdings released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.

4 weeks ago - Filings

Integer Holdings Quarterly report: Q1 2026

Integer Holdings has published its Q1 2026 quarterly earnings report on April 30, 2026.

4 weeks ago - Filings

Integer Holdings Corporation Reports First Quarter 2026 Results

~ First quarter results in line with February outlook ~ ~ Updates 2026 outlook ranges; continues to expect 200bps above-market organic sales growth in 2027 ~ PLANO, Texas, April 30, 2026 (GLOBE NEWSWI...

4 weeks ago - GlobeNewsWire

Integer Announces Strategic Review to Maximize Stockholder Value

PLANO, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced ...

4 weeks ago - GlobeNewsWire

Integer to Participate in Bank of America Healthcare Conference on May 12

PLANO, Texas, April 29, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced participation ...

5 weeks ago - GlobeNewsWire

Integer chair Pamela Bailey to step down, Donald Spence to succeed

Integer (ITGR) announced Pamela Bailey, who currently serves as Integer’s independent chair of the board, will not stand for re-election at the company’s 2026 annual meeting of stockholders, scheduled...

2 months ago - TheFly

Integer Announces Board Leadership Transition

PLANO, Texas, April 06, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced ...

2 months ago - GlobeNewsWire

Integer Holdings Proxy statement: Proxy filing

Integer Holdings filed a proxy statement on April 6, 2026, providing details for shareholder voting and corporate governance matters.

2 months ago - Filings

Integer Holdings Proxy statement: Proxy filing

Integer Holdings filed a proxy statement on April 6, 2026, providing details for shareholder voting and corporate governance matters.

2 months ago - Filings

Integer Announces Conference Call to Discuss First Quarter 2026 Results

PLANO, Texas, April 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), announced today ...

2 months ago - GlobeNewsWire

Integer Holdings Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

Management highlighted a smooth CEO transition, ongoing board refreshment, and a strategy focused on customer success and operational excellence. Temporary headwinds from three underperforming products are expected to subside by late 2026, with above-market growth targeted for 2027, driven by new product launches and a strong pipeline.

2 months ago - Transcripts

Integer Holdings Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Management reaffirmed its strategy, focusing on organic growth, tuck-in M&A, and resilience to macro shocks. Despite a $70M headwind from three products in 2026, robust pipeline growth and new launches are expected to drive above-market performance by 2027.

2 months ago - Transcripts

Integer enters cooperation agreement with Irenic Capital Management

Integer (ITGR) Holdings Corporation announced that James Flanagan has been appointed to the Board of Directors as an independent director. Additionally, in connection with a cooperation agreement with...

2 months ago - TheFly

Integer Appoints James Flanagan and Aaron Kapito to Board of Directors

~ Enters into Cooperation Agreement with Irenic Capital Management ~   PLANO, Texas, March 12, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contr...

2 months ago - GlobeNewsWire

Integer Holdings Transcript: 47th Annual Raymond James Institutional Investor Conference

A diversified MedTech manufacturer highlighted robust growth, a strong pipeline in high-growth markets, and disciplined capital allocation. Despite isolated 2026 headwinds from three products, the company expects to return to above-market growth in 2027, supported by new launches and a resilient business model.

3 months ago - Transcripts